PROactive Solutions for Prolonging Resilience (PROSPR)
ID: ARPA-H-SOL-25-125Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Washington, DC, 20005, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
    Description

    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at enhancing healthspan by addressing age-related health decline and chronic diseases. This initiative invites collaborations to develop innovative tools, such as an intrinsic capacity (IC) score, and is structured into three Technical Areas: developing the IC score and assessment technology (TA1), repurposing FDA-approved drugs (TA2), and clinical testing of interventions (TA3). The program seeks to transition to a preventive care model for aging populations, ultimately reducing healthcare costs associated with aging-related diseases. Interested parties can find more information and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with key deadlines and submission details outlined in the solicitation documents.

    Point(s) of Contact
    The PROSPR Team
    PROSPR@arpa-h.gov
    Files
    Title
    Posted
    The document outlines the ARPA-H solicitation for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at extending the healthspan of Americans by developing interventions that target the underlying causes of age-related health decline. The program includes establishing a predictive Intrinsic Capacity (IC) score, repurposing FDA-approved drugs, and testing second-generation interventions. The structured approach spans multiple technical areas over a five-year timeline, each with specific objectives, metrics, and phases, and engaging multidisciplinary teams to encourage collaboration. Key milestones include developing in-home assessment technologies, conducting decentralized clinical trials, and ensuring accessibility in health interventions. The program's ultimate goal is to create innovative preventative care models that reduce healthcare costs associated with chronic diseases while improving overall well-being for aging populations. Interested proposers are encouraged to attend a Proposers’ Day and submit questions via designated channels to promote participation and engagement.
    The Advanced Research Projects Agency for Health (ARPA-H) has issued a final Innovative Solutions Opening (ISO) titled "PROactive Solutions for Preserving Resilience" (PROSPR). The program aims to extend the healthspan of Americans by developing preventative interventions targeting the underlying causes of age-related health decline. Proposals are sought from eligible entities to negotiate multiple Other Transaction Agreements (OTs). The solicitation covers detailed program information, eligibility, submission, evaluation processes, and general requirements for proposers. The PROSPR program has a five-year scope and focuses on three technical areas: 1) development of an intrinsic capacity score to evaluate health outcomes, 2) repurposing FDA-approved interventions, and 3) creating second-generation interventions. Each area includes defined phases for development, trials, and metrics to measure progress. The program aims to transform geriatric medicine into a preventive care model, emphasizing accessibility and health equity. With a variety of innovative deliverables and collaborative approaches, PROSPR seeks to tackle the significant economic burden of chronic diseases and enhance proactive health management for aging populations. Key deadlines for submission are set for April and May 2025, and interested proposers can find more information on the ARPA-H website.
    The Advanced Research Projects Agency for Health (ARPA-H) launched the PROactive Solutions for Preserving Resilience (PROSPR) program through the Innovative Solutions Opening (ISO), aiming to extend Americans' healthspan by 20 years. This five-year initiative invites eligible applicants to propose interventions that focus on early disease prevention, targeting age-related health decline, which significantly affects healthcare costs. The program comprises three Technical Areas (TAs): 1. **TA1** focuses on developing a precise intrinsic capacity (IC) score to predict long-term health outcomes and creating an in-home assessment technology for continuous health monitoring. 2. **TA2** emphasizes the identification and repurposing of FDA-approved drugs to enhance healthspan, incorporating biomarkers from clinical trials to validate the effectiveness of these interventions. 3. **TA3** aims to test second-generation healthspan interventions through preclinical and first-in-human trials to evaluate safety and effectiveness. Proposers must ensure accessibility and inclusivity in their solutions, with a strong emphasis on regulatory compliance and collaboration across teams. The ISO timeline outlines key milestones, requiring participants to submit proposals by set deadlines and engage with regulatory bodies to establish innovative health interventions effectively.
    The ARPA-H's Innovative Solutions Opening (ISO) seeks proposals for the PROactive Solutions for Preserving Resilience (PROSPR) program, aiming to enhance healthspan by addressing age-related health decline and chronic diseases. This initiative encourages collaborations among various entities to develop tools like an intrinsic capacity (IC) score that predicts long-term health outcomes based on physiological and biochemical indicators. The program is structured into three main Technical Areas (TAs): 1. **TA1** focuses on developing the PROSPR IC score and in-home assessment technology to facilitate proactive health management and lifestyle intervention studies. 2. **TA2** involves repurposing FDA-approved drugs to extend healthspan, identifying intervenable biomarkers, and conducting clinical trials to explore combined therapies. 3. **TA3** emphasizes the clinical testing of second-generation interventions demonstrated to maintain or improve health in preclinical models. The selected proposals will be evaluated based on scientific merit, the proposer's capabilities, and budget considerations. The overall objective is to transition into a preventive care model for aging populations, targeting systemic changes in health outcomes through innovative therapeutic strategies, ultimately reducing healthcare costs associated with aging-related diseases.
    The ARPA-H Model Other Transaction Agreement pertains to the PROactive Solutions for Prolonging Resilience (PROSPR) program, which aims to develop interventions to extend healthspan by 20 years, addressing age-related health loss. The sample agreement outlines the terms and conditions for federal funding and project execution details, including project duration, management structure, deliverables, and financial obligations. Key components include the expectation for the Performer to manage the project, report milestones, and ensure compliance with regulations, particularly regarding human subjects and intellectual property rights. The agreement also details the Government's rights over inventions and data generated, emphasizing a collaborative approach while allowing flexibility for modifications. Lastly, the document emphasizes the importance of protecting intellectual property, especially regarding foreign access and security. This agreement serves as a framework for expedited negotiations for potential project awards, ensuring clarity in roles, responsibilities, and expected outcomes in advancing aging-related health interventions within a structured federal funding context.
    The document outlines a federal government Request for Proposal (RFP) focused on cost proposal submissions by potential contractors. Its primary purpose is to guide proposers in developing, structuring, and providing thorough cost proposals that will be assessed by government officials during the evaluation process. Key elements include a detailed breakdown of projected costs, such as direct labor, general and administrative (G&A), subcontractors, consultants, and other direct costs. The document stresses the importance of justifying cost estimates and requires proposers to offer a clear explanation and evidence supporting their suggested expenses. Proposers must complete various tabs in the provided spreadsheet for different periods, including cost summaries for each task in the statement of work, ensuring that all expenses align with the total amounts submitted. Furthermore, the document emphasizes that all cost entries need to be precise and reconciled across worksheets to facilitate a streamlined evaluation and negotiation if selected for contract award. Important considerations such as fiscal year definitions and applicable labor categories are also outlined, highlighting the significance of adhering to federal guidelines and standards in proposal submissions. Overall, the document serves as a comprehensive guide enhancing transparency and consistency in the RFP process.
    Similar Opportunities
    Resilient Systems Office (RSO) Mission Office Innovative Solutions Opening (ISO)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Resilient Systems Office (RSO) Mission Office Innovative Solutions Opening (ISO). This opportunity invites submissions that address systemic challenges in healthcare and public health by leveraging innovative technologies to improve care quality, efficacy, and accessibility. Proposals will be evaluated based on scientific merit, alignment with ARPA-H's mission, proposer capabilities, and cost, with a focus on open-source intellectual property and compliance with research regulations. Interested parties must submit solution summaries and proposals via the designated ARPA-H portal, with the closing date for submissions set for March 5, 2029. For further inquiries, proposers can reach out through the same portal.
    Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO). This initiative aims to gather innovative solutions that address future healthcare challenges, focusing on groundbreaking research in areas such as maternal/fetal medicine, genetic therapies, chronic diseases, and mental health, while excluding proposals for incremental advances or clinical trials. Proposers are required to submit a Solution Summary for initial feedback, followed by a detailed proposal that adheres to updated administrative and national policy requirements, including compliance with ethical research guidelines and research security disclosures. Interested parties should submit their proposals via the designated ARPA-H portal, with specific deadlines and further details available through the provided links.
    Scalable Solutions Office (SSO) Mission Office Innovative Solutions Opening (ISO)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) under the Scalable Solutions Office (SSO). This initiative aims to develop innovative solutions that enhance healthcare access, affordability, and distribution, particularly in underserved communities, while addressing challenges in biomanufacturing and health technology distribution. The solicitation is open until March 5, 2029, and encourages submissions from academia, non-profits, and for-profit entities, with multiple awards anticipated as Other Transactions. Interested parties must submit a Solution Summary for initial feedback before proceeding with a full proposal, adhering to strict guidelines on intellectual property, research security, and cost proposal requirements. For further details, proposers can reach out through the designated submission portals and must ensure compliance with the updated administrative and national policy requirements outlined in the solicitation documents.
    Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the "Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)" program. This initiative aims to accelerate the development of innovative precision genetic medicines (PGMs) to treat hereditary rare diseases, focusing on creating integrated platforms that address technical and real-world challenges in genetic medicine. Proposals must include a solution summary, a PowerPoint presentation, and a detailed Gantt chart, with key deadlines set for October 31, 2025, for solution summaries and December 22, 2025, for PowerPoint submissions. Interested parties can contact the THRIVE Program at THRIVE@arpa-h.gov for further information.
    MAKING OBSTETRIC CARE SMART (MOCS)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is seeking proposals for the Making Obstetric Care Smart (MOCS) program, which aims to revolutionize maternity care by developing data-driven solutions for labor and delivery. The initiative focuses on creating a point-of-care risk assessment tool for fetal hypoxia and a novel intrapartum fetal monitoring system utilizing multiplexed sensors and machine learning, emphasizing collaboration with clinical partners and stakeholder engagement. This 48-month program requires proposers to engage in mandatory pre-proposal discussions and submit their proposals by January 21, 2026, with further details available at the ARPA-H website. Interested parties should contact the designated email for inquiries and are encouraged to form teams early to enhance proposal quality.
    BioStabilization Systems (BoSS)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is seeking proposals for the BioStabilization Systems (BoSS) program aimed at revolutionizing the stabilization, manufacturing, and distribution of live cell-based therapies. The program addresses the critical challenge of ultra-cold storage requirements for advanced cell and gene therapies by developing bioprocessing systems that enable the production of thermally stable cells, thereby enhancing the efficiency and resilience of biologics distribution. Interested parties can submit Solution Summaries for consideration as either Performer teams or Independent Verification and Validation (IV&V) partners, with deadlines set for February 19, 2026, and April 17, 2026, respectively. For more information, including submission guidelines and program details, please visit the ARPA-H website or refer to the attached documents.
    Autonomous Interventions and Robotics (AIR) Advanced Research Projects Agency for Health (ARPA-H)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is seeking proposals for its Autonomous Interventions and Robotics (AIR) program, which aims to advance autonomous robotic surgery technologies. This initiative focuses on two technical areas: Autonomous Endovascular Robotics, which includes developing robotic systems for endovascular procedures and creating a simulation environment, and Microbots, which targets the development of untethered, autonomous microbots for various interventional procedures. The program is structured over a five-year timeline with specific phases and milestones, emphasizing collaboration with the FDA for regulatory approval. Interested parties are encouraged to attend a Proposers’ Day on December 16, 2025, in Washington, DC, to learn more about the program and network with potential collaborators. For further inquiries, contact the AIR Program at AIR@ARPA-H.GOV.
    Special Notice for BioStabilization Systems (BoSS)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is announcing a Special Notice for the BioStabilization Systems (BoSS) program, with a Proposers’ Day scheduled for January 29, 2026. This initiative aims to revolutionize the storage and transport of biological medicines by developing technologies that eliminate the need for ultra-cold conditions, and it seeks performer teams for breakthrough cell stabilization technologies and bioprocessing solutions, as well as an Independent Verification and Validation (IV&V) partner. The program is structured in three phases over four years, culminating in the transition of successful technologies to commercial partners, and encourages collaboration among teams. Interested parties can find more information and registration details on the ARPA-H website and should direct inquiries to the provided contact email, although it is noted that the email address should not be used for direct communication.
    GENETIC MEDICINES AND INDIVIDUALIZED MANUFACTURING FOR EVERYONE (GIVE)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program. This initiative aims to revolutionize the biomanufacturing of RNA-based genetic medicines by fostering innovations in automated RNA manufacturing and integrated quality control, ultimately enabling rapid, cost-effective, and localized production in non-GMP environments. Interested parties must submit solution summaries by December 19, 2025, with full proposals due by February 27, 2026, and are encouraged to participate in a Proposers’ Day on November 13, 2025, for further insights. For additional information, please refer to the program's website or contact the designated email address.
    Autonomous Interventions and Robotics (AIR) Advanced Research Projects Agency for Health (ARPA-H)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the "Autonomous Interventions and Robotics (AIR)" program, aimed at advancing autonomous robotic surgery solutions. This initiative focuses on two technical areas: Autonomous Endovascular Robotics, which involves developing robotic systems for procedures such as thrombectomy and embolization, and Microbots, which seeks to create untethered surgical microbots for various interventional applications. The program spans five years, divided into a two-year Phase 1 and a three-year Phase 2, with eligibility open to universities, non-profits, and businesses, while excluding FFRDCs and government entities. Interested parties should note the revised deadlines for submissions: the Solution Summary is due by January 20, 2026, and the Full Proposal by March 18, 2026. For further inquiries, contact the AIR Program at AIR@ARPA-H.GOV.